Dalliance Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
- Paid Up Capital ₹ 1.20 M
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 9.50 Cr
- Revenue Growth 208.02%
- Profit Growth 75.29%
- Ebitda 74.71%
- Net Worth 10.58%
- Total Assets 177.50%
About Dalliance Pharmaceuticals
Company Details
-
Location
Faridabad, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239HR2008PTC037770
-
Company No.
037770
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Mar 2008
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc-Delhi
Industry
Who are the key members and board of directors at Dalliance Pharmaceuticals?
Board Members
No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.
Financial Performance of Dalliance Pharmaceuticals.
Dalliance Pharmaceuticals Private Limited., for the financial year ended 2019, experienced significant growth in revenue, with a 208.02% increase. The company also saw a substantial improvement in profitability, with a 75.29% increase in profit. The company's net worth Soared by an impressive increase of 10.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dalliance Pharmaceuticals?
In 2019, Dalliance Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹95.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 9.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Mar 2020 | State Bank Of India | ₹9.50 Cr | Satisfied |
How Many Employees Work at Dalliance Pharmaceuticals?
Unlock and access historical data on people associated with Dalliance Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dalliance Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dalliance Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
